Status post TACE RFA. Assess for treatment response. ABDOMEN:LIVER, BILIARY TRACT: Cirrhotic liver morphology with fibrotic changes.Segment 6 ablation cavity measuring 5.0 x 4.6 cm without evidence of marginal recurrent or residual disease. Mild intrinsic T1 weighted signal intensity.No suspicious arterial enhancing or washing out liver lesion.Cholelithiasis without evidence of acute cholecystitis. No intra or extrahepatic biliary ductal dilatation. The portal and hepatic veins are patent.Trace perihepatic ascites.SPLEEN: Splenomegaly, measuring 18 cm in AP dimension. Trace perisplenic ascites.PANCREAS: Multiple small peripancreatic and porta hepatis lymph nodes, nonspecific in the setting of chronic liver disease. No pancreatic ductal dilatation or focal lesion. No peripancreatic inflammatory changes.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: No significant abnormality noted.RETROPERITONEUM, LYMPH NODES: Multiple small peripancreatic and porta hepatis lymph nodes, nonspecific in the setting of chronic liver disease. BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
Posttreatment changes from segment 6 radiofrequency ablation without evidence of residual or recurrent disease. No new suspicious liver lesion.Cirrhosis with trace ascites and splenomegaly.